Literature DB >> 9972503

Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte.

C Freitas1, R H Müller.   

Abstract

The contribution of mono-, di- and trivalent ions to the destabilization of solid lipid nanoparticle (SLN) dispersions was investigated, i.e. particle growth and subsequent formation of semi-solid gels. Sodium, calcium and aluminium chloride were added in varying concentrations to a Compritol formulation which had proved to be highly sensitive towards destabilizing effects. Dispersions containing up to 10(-3) M sodium chloride remained stable for 14 days. The same concentrations of calcium or aluminium induced slight and rapid particle growth, respectively. Generally, a pronounced destabilizing effect was observed with increasing electrolyte concentration and increasing valence. Higher concentrations of electrolyte (10(-2), 10(-1) M) induced gelation of the systems. The extent of solidification was highly dependent on the crystallinity of the lipid phase. The recrystalization indices of the gels were distinctly higher compared to the liquid systems. Additionally, unstable modifications, being present in liquid dispersions, were transformed into stable ones with increasing solidification. The mechanisms of the destabilizing effect of the electrolytes are reduced electrostatic repulsion and transformation of the lipid Compritol to the beta' modification promoting gel formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9972503     DOI: 10.1080/026520499289310

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  8 in total

1.  Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.

Authors:  S N Shrotriya; N S Ranpise; B V Vidhate
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 2.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

3.  Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.

Authors:  Pankaj Pathak; Mangal Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2009-07-30       Impact factor: 3.246

4.  Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake.

Authors:  Jana Stecová; Wolfgang Mehnert; Tobias Blaschke; Burkhard Kleuser; Ramadurai Sivaramakrishnan; Christos C Zouboulis; Holger Seltmann; Hans Christian Korting; Klaus D Kramer; Monika Schäfer-Korting
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

5.  Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies.

Authors:  Mubashar Rehman; Ayesha Ihsan; Asadullah Madni; Sadia Zafar Bajwa; Di Shi; Thomas J Webster; Waheed S Khan
Journal:  Int J Nanomedicine       Date:  2017-11-21

Review 6.  Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery.

Authors:  Eliana B Souto; Joana F Fangueiro; Ana R Fernandes; Amanda Cano; Elena Sanchez-Lopez; Maria L Garcia; Patrícia Severino; Maria O Paganelli; Marco V Chaud; Amélia M Silva
Journal:  Heliyon       Date:  2022-02-11

7.  Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies.

Authors:  Kesavan Bhaskar; Jayaraman Anbu; Velayutham Ravichandiran; Vobalaboina Venkateswarlu; Yamsani Madhusudan Rao
Journal:  Lipids Health Dis       Date:  2009-02-26       Impact factor: 3.876

Review 8.  Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.

Authors:  Imed Montasser; Patrick Shahgaldian; Florent Perret; Anthony W Coleman
Journal:  Int J Mol Sci       Date:  2013-11-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.